NCT00533455View on ClinicalTrials.gov

Gabapentin for the Treatment of Neuroleptic-Induced Tremor

PHASE3TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

August 31, 2007

Conditions
Neuroleptic-Induced Tremor
Interventions
DRUG

Gabapentin

Trial Locations (1)

55417

Minneapols VA Medical Center, Minneapolis

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Minneapolis Veterans Affairs Medical Center

FED

NCT00533455 - Gabapentin for the Treatment of Neuroleptic-Induced Tremor | Biotech Hunter | Biotech Hunter